Recro Pharma Inc. (REPH): Largest Shareholder Broadfin Capital Buys Even More Shares

Page 2 of 8 – SEC Filing

CUSIP No.
75629F109
1.
NAME OF REPORTING PERSONS
I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (ENTITIES ONLY)
Broadfin Capital, LLC
2.
CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP*
(a)
[_]
(b)
[x]
3.
SEC USE ONLY
4.
SOURCE OF FUNDS
AF, WC
5.
CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEMS 2(d) OR 2(e)
[_]
6.
CITIZENSHIP OR PLACE OF ORGANIZATION
Delaware
NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH
7.
SOLE VOTING POWER
0
8.
SHARED VOTING POWER
2,450,086
9.
SOLE DISPOSITIVE POWER
0
10.
SHARES DISPOSITIVE POWER
2,450,086
11.
AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING
PERSON
2,450,086
12.
CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES
[_]
CERTAIN SHARES*
13.
PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)
20.66%
14.
TYPE OF REPORTING PERSON
OO

Follow Recro Pharma Inc. (NASDAQ:REPH)